0000899243-21-039956.txt : 20211012
0000899243-21-039956.hdr.sgml : 20211012
20211012202002
ACCESSION NUMBER: 0000899243-21-039956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211008
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stacey Jennifer Evans
CENTRAL INDEX KEY: 0001321326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 211319871
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 160 WEST GERMANTOWN PIKE
CITY: NORRISTOWN
STATE: PA
ZIP: 19401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-08
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001321326
Stacey Jennifer Evans
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
0
1
0
0
See Remarks
Stock Option (Right to Buy)
7.84
2021-10-08
4
A
0
130000
0.00
A
2031-10-07
Common Stock
130000
130000
D
The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter.
Chief Legal and Compliance Officer
/s/ J. Mel Sorensen, Attorney-in-Fact for Jennifer Evans Stacey
2021-10-12